Embecta Corp. (EMBC)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Embecta Corp. (EMBC)
Company Performance

Current Price

as of Oct 21, 2024

$14.03

P/E Ratio

11.62

Market Cap

$809.56M

Description

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Metrics

Overview

  • HQParsippany, NJ
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerEMBC
  • Price$14.03+2.86%

Trading Information

  • Market Cap$809.56M
  • Float93.68%
  • Average Daily Volume (1m)336,766
  • Average Daily Volume (3m)403,249
  • EPS$1.21

Company

  • Revenue$1.12B
  • Rev Growth (1yr)-4.75%
  • Net Income$14.70M
  • Gross Margin68.95%
  • EBITDA Margin34.06%
  • EBITDA$92.80M
  • EV$2.09B
  • EV/Revenue1.87
  • P/E11.62
  • P/S0.73
  • P/BN/A
Documents
SEC Filings
8-K (2024-08-12)
8-K (2024-08-09)
8-K (2024-05-09)
8-K (2024-03-28)
8-K (2024-02-09)
8-K (2023-11-21)
8-K (2023-08-08)
8-K (2023-08-03)
8-K (2023-07-05)
8-K (2023-05-12)
8-K (2023-02-14)
8-K (2023-02-13)
10-Q (2024-08-09)
10-Q (2024-05-09)
10-Q (2024-02-09)
10-Q (2023-08-08)
10-Q (2023-05-12)
10-Q (2023-02-14)
10-K (2023-11-29)
Earnings Calls
Earnings Report 2024Q3
Earnings Report 2024Q2
Earnings Report 2024Q1
Earnings Report (2023-11-21)
Earnings Report (2023-08-13)
Factset Street Account
StreetAccount Earnings Call Q&A Summary: Embecta Q4 ($16.33, 0.00) (2023-11-21T13:27:22Z)
Embecta reports Q4 adjusted EPS $0.59 vs FactSet $0.40 [4 est, $0.37-0.47] ($16.33, 0.00) (2023-11-21T10:33:56Z)
Embecta confirms its syringes not impacted by yesterday's FDA safety communication ($18.19, 0.00) (2023-12-01T13:46:51Z)